Clinical Trials Logo

Clinical Trial Summary

Cystic fibrosis (CF) is a genetic disease that affects many organs and systems, especially respiratory system problems due to lung damage. Patients often have difficulty in removing the sticky and viscous secretion that accumulates in the respiratory tract, and the risk of mortality increases with the development of respiratory failure. In patients with CF, exercise capacity, peripheral muscle strength, core endurance, flexibility, motor performance, postural stability, physical activity level, and quality of life also decrease secondarily. Recently published guidelines recommend respiratory physiotherapy for coping with CF-related symptoms and recommend referral of patients to physical activity and exercise. Hippotherapy simulator is a mechanical exercise tool that imitates the walking movement of a real horse and is used to increase physical fitness parameters. This study aims to show the effects of exercises performed with a hippotherapy simulator in addition to respiratory physiotherapy on physical fitness, sputum production, physical activity and quality of life of children with CF.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05027503
Study type Interventional
Source Istanbul University-Cerrahpasa
Contact Betül Çinar, MSc
Phone +905327879969
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date October 19, 2021
Completion date June 19, 2022

See also
  Status Clinical Trial Phase
Completed NCT03637504 - Feasibility of a Mobile Medication Plan Application in CF Patient Care N/A
Recruiting NCT04602468 - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) Phase 4
Recruiting NCT04392544 - Intestinal Inflammation in CF Patients
Completed NCT04084041 - Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis N/A
Not yet recruiting NCT03292718 - Clinical Trial to Assess Influence of MyCyFAPP Use on GI Related QOL in Children With Cystic Fibrosis N/A
Recruiting NCT04174664 - Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary Exacerbation
Recruiting NCT04138589 - Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway Function
Active, not recruiting NCT03579173 - Determinants of Early Cystic Fibrosis Lung Disease
Active, not recruiting NCT04463628 - Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic
Completed NCT04293926 - Heart Rate Variability in Children and Adolescents With Cystic Fibrosis N/A
Completed NCT04987567 - Effect of Antioxidant Docosahexaenoic Acid (DHA) in Cystic Fibrosis Patients N/A
Recruiting NCT04415268 - Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis N/A
Recruiting NCT03939065 - Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management N/A
Recruiting NCT04613128 - The PROMISE Pediatric Study 6 to 11 Years Old
Withdrawn NCT03522480 - The Effectiveness of the Jamboxx Respiratory Therapy Device: Study 2 N/A
Recruiting NCT04705636 - Use of a Connected Companion in Children With Cystic Fibrosis N/A
Completed NCT04153669 - Exercise With or Without Electrical Stimulation in Cystic Fibrosis (Part I): Effects on Physical Fitness N/A
Recruiting NCT04301856 - Response to CFTR Modulators in CF Patients Under 18 Years
Completed NCT03635762 - Developing e-Health Systems to Improve Growth and Nutrition in CF N/A
Recruiting NCT03273959 - Program Of Exercises During The Hospitalization Of Children And Adolescents With Cystic Fibrosis N/A